Literature DB >> 22669117

Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.

Yan Pan1, Li-jun Zhong, Hong Zhou, Xin Wang, Kui Chen, Hao-peng Yang, Yilixiati Xiaokaiti, Aikebaier Maimaiti, Ling Jiang, Xue-jun Li.   

Abstract

AIM: To investigate the inhibitory effects of heparin on PC-3M cells proliferation in vitro and B16-F10-luc-G5 cells metastasis in Balb/c nude mice and identify the protein expression patterns to elucidate the action mechanism of heparin.
METHODS: Human prostate cancer PC-3M cells were incubated with heparin 0.5 to 125 μg/mL for 24 h. The proliferation of PC-3M cells was assessed by MTS assay. BrdU incoporation and Ki67 expression were detected using a high content screening (HCS) assay. The cell cycle and apoptosis of PC-3M cells were tested by flow cytometry. B16-F10-luc-G5 cardinoma cells were injected into the lateral tail vein of 6-week old male Balb/c nude mice and heparin 30 mg/kg was administered iv 30 min before and 24 h after injection. The metasis of B16-F10-luc-G5 cells was detected by bioluminescence assay. Activated partial thromboplastin time (APTT) and hemorheological parameters were measured on d 14 after injection of B16-F10-luc-G5 carcinoma cells in Balb/c mice. The global protein changes in PC-3M cells and frozen lung tissues from mice burdened with B16-F10-luc-G5 cells were determined by 2-dimensional gel electrophoresis and image analysis. The protein expression of vimentin and 14-3-3 zeta/delta was measured by Western blot. The mRNA transcription of vimentin, transforming growth factor (TGF)-β, E-cadherin, and α(v)-integrin was measured by RT-PCR.
RESULTS: Heparin 25 and 125 μg/mL significantly inhibited the proliferation, arrested the cells in G(1) phase, and suppressed BrdU incorporation and Ki67 expression in PC-3M cells compared with the model group. But it had no significant effect on apoptosis of PC-3M cells. Heparin 30 mg/kg markedly inhibits the metastasis of B16-F10-luc-G5 cells on day 8. Additionally, heparin administration maintained relatively normal red blood hematocrit but had no influence on APTT in nude mice burdened with B16-F10-luc-G5 cells. Thirty of down-regulated protein spots were identified after heparin treatment, many of which are related to tumor development, extracellular signaling, energy metabolism, and cellular proliferation. Vimentin and 14-3-3 zeta/delta were identified in common in PC-3M cells and the lungs of mice bearing B16-F10-luc-G5 carcinoma cells. Heparin 25 and 125 μg/mL decreased the protein expression of vimentin and 14-3-3 zeta/delta and the mRNA expression of α(v)-integrin. Heparin 125 μg/mL decreased vimentin and E-cadherin mRNA transcription while increased TGF-β mRNA transcription in the PC-3M cells, but the differences were not significant. Transfection of vimentin-targeted siRNA for 48 h significantly decreased the BrdU incoporation and Ki67 expression in PC-3M cells.
CONCLUSION: Heparin inhibited PC-3M cell proliferation in vitro and B16-F10-luc-G5 cells metastasis in nude mice by inhibition of vimentin, 14-3-3 zeta/delta, and α(v)-integrin expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22669117      PMCID: PMC4010382          DOI: 10.1038/aps.2012.42

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  26 in total

1.  Disseminating effect of heparin on experimental tumour metastases.

Authors:  B Hagmar; B Boeryd
Journal:  Pathol Eur       Date:  1969

Review 2.  Heparin lowers blood pressure: biological and clinical perspectives.

Authors:  A K Mandal; T W Lyden; M G Saklayen
Journal:  Kidney Int       Date:  1995-04       Impact factor: 10.612

3.  Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group.

Authors:  B Lebeau; C Chastang; J M Brechot; F Capron; B Dautzenberg; C Delaisements; M Mornet; J Brun; J P Hurdebourcq; E Lemarie
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

4.  Effect of heparin and plasminogen inhibitor (EACA) in brief and prolonged treatment on intravenously injected tumour cells.

Authors:  B Boeryd
Journal:  Acta Pathol Microbiol Scand       Date:  1966

Review 5.  Targeting 14-3-3zeta in cancer therapy.

Authors:  X Yang; W Cao; L Zhang; W Zhang; X Zhang; H Lin
Journal:  Cancer Gene Ther       Date:  2011-12-23       Impact factor: 5.987

Review 6.  Mechanisms of heparin induced anti-cancer activity in experimental cancer models.

Authors:  T M H Niers; C P W Klerk; M DiNisio; C J F Van Noorden; H R Büller; P H Reitsma; D J Richel
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-30       Impact factor: 6.312

7.  Identification of aquaporin-5 and lipid rafts in human resting saliva and their release into cevimeline-stimulated saliva.

Authors:  Yan Pan; Fusako Iwata; Di Wang; Masahiro Muraguchi; Keiko Ooga; Yasukazu Ohmoto; Masaaki Takai; Gota Cho; Jinsen Kang; Masayuki Shono; Xue-jun Li; Ko Okamura; Toyoki Mori; Yasuko Ishikawa
Journal:  Biochim Biophys Acta       Date:  2008-09-10

8.  The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes.

Authors:  Jun-Ichi Satoh; Takashi Yamamura; Kunimasa Arima
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.

Authors:  M Altinbas; H S Coskun; O Er; M Ozkan; B Eser; A Unal; M Cetin; S Soyuer
Journal:  J Thromb Haemost       Date:  2004-08       Impact factor: 5.824

10.  Extrapulmonary colony formation after intravenous injection of tumour cells into heparin-treated animals.

Authors:  B Maat
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640

View more
  8 in total

Review 1.  Pathophysiological Role of Vimentin Intermediate Filaments in Lung Diseases.

Authors:  Ranu Surolia; Veena B Antony
Journal:  Front Cell Dev Biol       Date:  2022-04-28

2.  Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Vincenzo Costigliola; Daniela Trog; Michael Braun; Manuel Debald; Walther Kuhn; Hans H Schild
Journal:  EPMA J       Date:  2013-02-19       Impact factor: 6.543

3.  Nanodiamonds coupled with 5,7-dimethoxycoumarin, a plant bioactive metabolite, interfere with the mitotic process in B16F10 cells altering the actin organization.

Authors:  Angelo Gismondi; Valentina Nanni; Giacomo Reina; Silvia Orlanducci; Maria Letizia Terranova; Antonella Canini
Journal:  Int J Nanomedicine       Date:  2016-02-03

4.  EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC.

Authors:  Jiao Meng; Cuicui Chang; Yuhua Chen; Fangfang Bi; Chen Ji; Wei Liu
Journal:  Onco Targets Ther       Date:  2019-07-26       Impact factor: 4.147

5.  GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism.

Authors:  Qianqian Shi; Renfang Xu; Guanglai Song; Hao Lu; Dong Xue; Xiaozhou He; Ying Xia
Journal:  Cancer Gene Ther       Date:  2019-10-21       Impact factor: 5.854

6.  Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure.

Authors:  Kiriaki Panagopoulos; Sam Cross-Knorr; Christen Dillard; Dionysios Pantazatos; Michael Del Tatto; David Mills; Lisa Goldstein; Joseph Renzulli; Peter Quesenberry; Devasis Chatterjee
Journal:  Mol Cancer       Date:  2013-10-08       Impact factor: 27.401

7.  EGCG protects vascular endothelial cells from oxidative stress-induced damage by targeting the autophagy-dependent PI3K-AKT-mTOR pathway.

Authors:  Jiao Meng; Yuhua Chen; Junzhe Wang; Junling Qiu; Cuicui Chang; Fangfang Bi; Xiaopeng Wu; Wei Liu
Journal:  Ann Transl Med       Date:  2020-03

8.  Molecular Mechanisms by Which S100A4 Regulates the Migration and Invasion of PGCCs With Their Daughter Cells in Human Colorectal Cancer.

Authors:  Fei Fei; Kai Liu; Chunyuan Li; Jiaxing Du; Zhen Wei; Bo Li; Yuwei Li; Yi Zhang; Shiwu Zhang
Journal:  Front Oncol       Date:  2020-02-21       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.